Add Company
Join Now

NeoTX Therapeutics LTD Revenue and Competitors

License our Company Data API

Rehovot,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NeoTX Therapeutics LTD's estimated annual revenue is currently $3.1M per year.(i)
  • NeoTX Therapeutics LTD's estimated revenue per employee is $155,000

Employee Data

  • NeoTX Therapeutics LTD has 20 Employees.(i)
  • NeoTX Therapeutics LTD grew their employee count by -41% last year.

NeoTX Therapeutics LTD's People

NameTitleEmail/Phone
1
Executive Personal AssistantReveal Email/Phone
2
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is NeoTX Therapeutics LTD?

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$3.1M

Revenue (est)

-41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NeoTX Therapeutics LTD News

2022-04-19 - Active Biotech strengthens the patent protection for laquinimod in eye disorders - Benzinga

(Limited Seating Event) ... Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a phase Ib/II clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M2310%N/A
#2
$4.7M2514%N/A
#3
$6.5M2618%N/A
#4
$3.5M31-33%N/A
#5
$3.6M3141%N/A